Literature DB >> 11841401

Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukaemia cell invasion.

Toshihisa Hayashibara1, Yasuaki Yamada, Yasuyuki Onimaru, Chizuko Tsutsumi, Susumu Nakayama, Naoki Mori, Takayuki Miyanishi, Shimeru Kamihira, Masao Tomonaga, Tetsuo Maita.   

Abstract

Plasma from a total of 57 patients with adult T-cell leukaemia (ATL) (acute ATL, 39 patients; lymphoma ATL, one patient; chronic ATL, 15 patients; smouldering ATL, two patients) and 20 healthy controls was analysed for the presence of type IV gelatinase activity with clinical features. A significant elevation of plasma matrix metalloproteinase-9 (MMP-9) was observed in some ATL patients, particularly in the patients with malignant cell infiltration. MMP-9 was found to be secreted into the conditioned medium from all ATL cell lines examined. Moreover, the corresponding mRNA was detectable both in all ATL cell lines examined and in the majority of primary acute ATL cells, indicating that ATL cells are capable of synthesizing and secreting MMP-9. We previously demonstrated that a high incidence of ATL cell infiltration was closely related to a high plasma level of vascular endothelial growth factor (VEGF) produced by ATL cells themselves. This present study showed that the presence of increased plasma MMP-9 was closely associated with elevated plasma VEGF in ATL patients. Furthermore, we showed that both increased plasma MMP-9 and VEGF were significantly related to high ATL cell infiltration. All these findings strongly suggest that MMP-9 and VEGF act co-operatively in the process of ATL cell invasion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11841401     DOI: 10.1046/j.1365-2141.2002.03255.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

Review 1.  Adult T cell leukemia lymphoma.

Authors:  Lee Ratner
Journal:  Front Biosci       Date:  2004-09-01

Review 2.  Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise.

Authors:  M P Bernard; S Bancos; P J Sime; R P Phipps
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias.

Authors:  Sandrine Bouchet; Brigitte Bauvois
Journal:  Cancers (Basel)       Date:  2014-04-04       Impact factor: 6.639

4.  The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study.

Authors:  Arianna Aricò; Mery Giantin; Maria Elena Gelain; Fulvio Riondato; Stefano Comazzi; Barbara C Rütgen; Sabine E Essler; Mauro Dacasto; Massimo Castagnaro; Luca Aresu
Journal:  BMC Vet Res       Date:  2013-05-03       Impact factor: 2.741

5.  Clinical significance of sIL-2R levels in B-cell lymphomas.

Authors:  Noriaki Yoshida; Miyo Oda; Yoshiaki Kuroda; Yuta Katayama; Yoshiko Okikawa; Taro Masunari; Megumu Fujiwara; Takashi Nishisaka; Naomi Sasaki; Yoshito Sadahira; Keichiro Mihara; Hideki Asaoku; Hirotaka Matsui; Masao Seto; Akiro Kimura; Koji Arihiro; Akira Sakai
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.